Search clinical trials for: Fulvestrant
Total 472 results
-
Fudan UniversityCompleted
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland, Belgium
-
Zhimin ShaoCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedBreast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedBreast CancerUnited States
-
Xijing HospitalUnknown
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownRecurrent Uterine Corpus Carcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7
-
Translational Oncology Research InternationalNational Cancer Institute (NCI)Completed
-
Fudan UniversityCompleted
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
CelgeneTerminatedBreast NeoplasmsSpain, United States, Belgium, Italy, France, Germany
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownEstrogen Receptor-positive Breast Cancer | FulvestrantChina
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor PositiveUnited States
-
National Cancer Institute (NCI)WithdrawnEstrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7
-
Ohio State University Comprehensive Cancer CenterPfizerCompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Sun Yat-sen UniversityAstraZenecaUnknown
-
Assistance Publique - Hôpitaux de ParisUnknownBreast Cancer | Metastasis | HR+/HER2-negative Breast Cancer
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States
-
PrECOG, LLC.NovartisCompletedMetastatic Breast CancerUnited States
-
Ramón Óscar González-Ramella, Ph.DHospital Civil Juan I. Menchaca; Instituto de Investigacion en Cancer de la... and other collaboratorsUnknownAcute Lymphoblastic LeukemiaMexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Novartis PharmaceuticalsCompletedSolid TumorsAustria, Belgium, United States, Italy, Denmark, Spain, Japan
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Terminated
-
Western Regional Medical CenterTerminatedHER2-positive Breast Cancer | ER-positive Breast CancerUnited States
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
Masonic Cancer Center, University of MinnesotaCompletedOvarian CancerUnited States
-
AstraZenecaTerminated
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Withdrawn
-
Cairo UniversityCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of PittsburghTerminatedNon-small Cell Lung Cancer | Postmenopausal WomenUnited States
-
Fondazione Sandro PitiglianiCompleted
-
Fudan UniversityUnknown
-
SanofiRegeneron PharmaceuticalsCompletedNasal PolypsSpain, Belgium, United States, Sweden
-
National University Hospital, SingaporeUnknown
-
Lyudmila Bazhenova, M.D.AstraZenecaTerminatedNon Small Cell Lung CarcinomaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
Fresenius KabiCompleted
-
Mara ChambersNovartisCompleted
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Genzyme, a Sanofi CompanyTerminated
-
Genentech, Inc.CompletedBreast CancerBelgium, Israel, United States, Spain, Denmark, Germany, Hong Kong, Russian Federation, Australia, New Zealand, Korea, Republic of, Malaysia, Singapore, Italy, Czech Republic, France, Peru, Canada, United Kingdom, Chile, Thailand, Argentin... and more
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland